Prevalence
Clinical
features
Investigations
Therapy
Prevention
Prognosis
|  |  | | Clinical
features |
Ask about
-
valvular heart disease
b
(including mitral valve prolapse)
b
-
which valves are affected
b
-
severity of disease
b
-
any recent valvular surgery in the last 2 months
a
-
any prosthetic valves
b
-
previous rheumatic fever
b
-
previous endocarditis
b
-
intravenous drug use
b
-
any infectious episode in the last 3 months
b
particularly superficial wound infections
a
-
any skin wounds in the last 3 months b
Ask about any skin wounds in the last 3 months
b
Note:
- Recent dental, surgical or medical procedures do not clearly predict an increased risk of developing infective
endocarditis.
b
Why?
Valvular heart disease, valvular surgery or previous endocarditis increases the risk of developing infective endocarditis
Outcome b  |
Risk Factor |
PEER |
OR (95% CI) |
NNH
(95% CI) |
infective endocarditis
|
severe valvular heart disease (mixed or prosthetic valves)
independent
|
0.0050% |
131 (6.9 to
2490) |
160
(9 to
3400)
|
|
cardiac valvular surgery
independent
|
0.0050% |
74.6 (12.5 to
447) |
270
(46 to
1700)
|
|
previous episode of endocarditis
independent
|
0.0050% |
37.2 (4.4 to
317) |
550
(64 to
5900)
|
|
known mitral valve prolapse
independent
|
0.0050% |
19.4 (6.4 to
58.4) |
1100
(350 to
3700)
|
|
any cardiac valvular abnormality
independent
|
0.0050% |
16.7 (7.4 to
37.4) |
1300
(550 to
3100)
|
|
rheumatic fever
independent
|
0.0050% |
13.4 (4.5 to
39.5) |
1600
(520 to
5700)
|
|
infectious episode
independent
|
0.021% |
3.9 (2.1 to
7.3) |
1600
(760 to
4300)
|
|
|
skin wound
independent
|
0.021% |
3.9 (1.6 to
9.6) |
1600
(560 to
7900)
|
|
|
congenital heart disease
independent
|
0.0050% |
6.7 (2.3 to
19.4) |
3500
(1100 to
15000)
|
|
|
heart murmur
independent
|
0.0050% |
4.2 (2.0 to
8.9) |
6300
(2500 to
20000)
|
|
|
any dental procedure
independent
|
0.0050% |
1.4 (0.7 to
2.7) |
50000
(-67000 to
12000)
|
Prosthetic valves, wound infections,
hypoxia
and active endocarditis increase the risk of infective endocarditis following valve surgery
| Patient |
Prognostic Factor |
Outcome |
CER |
RR (95% CI) |
NNF+
(95% CI) |
prosthetic valve replacement in last 2 months
a
|
superficial wound infection
independent
|
infective endocarditis
at
8
years
|
1.3%
(0.7% to 2.0%)
|
3.5 |
9
|
|
|
preoperative
hypoxia (pO2
< 80 mmHg)
independent
|
infective endocarditis
at
8
years
|
1.3%
(0.7% to 2.0%)
|
7.9 |
11
|
|
|
active endocarditis
independent
|
infective endocarditis
at
8
years
|
1.3%
(0.7% to 2.0%)
|
6.8 |
13
|
|
|
resident as primary surgeon
independent
|
infective endocarditis
at
8
years
|
1.3%
(0.7% to 2.0%)
|
3.2 |
34
|
|
|
preoperative valve lesion
independent
|
infective endocarditis
at
8
years
|
1.3%
(0.7% to 2.0%)
|
|
|
|